• Director of Business & Clinical Development

Dr. Erin Tireman is a clinical neuropsychologist with over 16 years of clinical experience in conducting psychological and neuropsychological testing with a clinical background in the treatment of various psychological disorders including major depressive disorder, post-traumatic stress disorder, bipolar disorder, ADHD, psychotic disorders, substance use disorders, developmental disorders and neurologic disorders in children, adolescents, adults and geriatrics. She obtained her Masters and Doctoral degrees in Clinical Psychology with a specialization in Neuropsychology from Nova Southeastern University and her Bachelor’s Degree in Psychology from Loyola University of New Orleans.  Dr. Tireman has also pursued a partial post-doctoral Master’s Degree in Clinical Psychopharmacology, which has enhanced her knowledge in the area of central nervous system pharmacological research.

Dr. Tireman has an extensive history in research, with nearly 12 years of clinical trial experience within Segal Trials.  Her clinical trial experience began as a Clinical Rater, conducting efficacy measures on multiple clinical trials and in multiple indications.  She has also functioned as a sub-investigator, assisting the principal investigators throughout the clinical trial processes.  Throughout her 10 years at Segal Trials, Dr. Tireman was promoted to Clinical Rater Supervisor and oversaw all of the rating team for emphasis on training, inter-rater reliability and placebo response mitigation.

Currently, Dr. Tireman is Director of Business & Clinical Development for the Segal Trials Site Network.  As Director of Business & Clinical Development, she is responsible for the business aspects of clinical operations, including providing project management and business development for the network to ensure all Segal Trials’ objectives are met, as well as oversight of recruitment and marketing.  She creates and manages business operations and relationships as needed to ensure that enrollment goals/site performance and compliance standards are met to lead company growth.  Additionally, she integrates with all of the departments within the network including New Business Development, Marketing, Recruitment, Finance, and Human Resources (HR) to ensure enterprise success and building integrative initiatives to create corporate collaboration, establishing programs in line with the company mission, vision and values, and ensuring the company maximizes productivity and efficiencies.  Dr. Tireman also interfaces with the FDA and has been directly involved with over 7 FDA inspections, and stays current on regulations affecting life science research.

Dr. Tireman has a strong focus on quality across all clinical departments and has implemented quality assurance and quality control programs throughout our organization with internal and external professionals.  Working directly with the Clinical Operations Manager, she has been involved in the development of multiple company-wide trainings and abstracts/poster presentations related to quality and placebo response mitigation.  She is responsible for assisting with site expansion and growth and maintains data on forecasting and projections, along with maintaining qualitative and quantitative metrics on site performance and quality.

Dr. Tireman was directly involved in expanding the network to include our newest facility, Miami Lakes Medical Research.  She has been involved in the start-up and oversight of the company’s first freestanding research unit and all aspects involved in its development and facilitation of the initiation of studies in the facility.